2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

Code: 
2100

Most active institutional investors by number of deals

Investor Profile Country Deals
Tragara Pharmaceuticals Inc Development of proprietary drugs for the treatment of cancer and inflammation-related disorders. United States 1
WuXi AppTec Co Ltd WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device outsourcing company. 1

Pages

Selected companies

Company type: 
Drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases.
Company type: 
Pharmaceutical company focused on the development and commercialization of proprietary oral sorbent technology.
Company type: 
Specialty pharmaceutical company, focused on pediatric neurology.
Company type: 
Developer of “smart” therapeutic targeted nano-particles capable of differential delivery and controlled drug release to diseased tissue
Subscribe to RSS - 2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products